The National Institute of One Health (NIOH), currently being established in Nagpur, will feature a specialised National Outbreak Response Team aimed at swiftly identifying and analysing the root causes of disease outbreaks.
Dr Krishna Ella, Executive Chairman at Bharat Biotech, expressed enthusiasm about the agreement, stating, "This agreement reflects our ethos to facilitate collaborative research, foster innovation, and further advance the science vaccine technology".
A mechanism that caused some individuals to have fatal clotting after receiving certain forms of Covid-19 immunisation has been revealed in recent research.
In a new study, mice with immune systems that had been trained against the microbial protein flagellin did not experience the usual negative consequences of consuming food additive emulsifiers, pointing to a potential new strategy to battle many chronic inflammatory disorders.
Union Health Minister Mansukh Mandaviya on Saturday addressed the Global Vaccine Research Collaborative Discussion on Vaccine Research and Development, a G20 co-branded event in Telangana's Hyderabad.
Mansukh Mandaviya, Minister of Health and Family Welfare, said BRICS Vaccine Research and Development Center can play a vital role in providing equitable access to safe, efficacious, and affordable vaccines.
A clinical trial of an experimental universal influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Centre (VRC), which is part of the National Institutes of Health, has begun at Duke University in Durham, North Carol
ccording to Okinawa Institute of Science and Technology researchers, gut bacteria that break down a sugar called fucose may be suppressing our immune response to the COVID-19 mRNA vaccine (OIST).
According to a new meta-analysis of the association between sleep duration and the body's reaction to vaccination, how well a vaccine protects you may rely on obtaining enough sleep in the days before and after immunisation.
A new vaccine from the University of Georgia could be the first clinically approved immunization to protect against invasive fungal infections, a growing concern as antifungal drug resistance increases.
As the Covid-19 pandemic showed, potentially dangerous new viruses can begin to spread in the population well before the global public health surveillance system can detect them.
New research from the University of Virginia School of Medicine speaks to the benefits of a Covid-19 booster. The new findings shed light on how mRNA boosters - both Pfizer and Moderna - affect the durability of our antibodies to Covid-19. A booster, the researchers report, made for longer-l